These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Complement activation in diseases presenting with thrombotic microangiopathy. Meri S Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117 [TBL] [Abstract][Full Text] [Related]
3. Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome. Westra D; Volokhina EB; van der Molen RG; van der Velden TJ; Jeronimus-Klaasen A; Goertz J; Gracchi V; Dorresteijn EM; Bouts AH; Keijzer-Veen MG; van Wijk JA; Bakker JA; Roos A; van den Heuvel LP; van de Kar NC Pediatr Nephrol; 2017 Feb; 32(2):297-309. PubMed ID: 27718086 [TBL] [Abstract][Full Text] [Related]
4. STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Noris M; Mescia F; Remuzzi G Nat Rev Nephrol; 2012 Nov; 8(11):622-33. PubMed ID: 22986360 [TBL] [Abstract][Full Text] [Related]
5. Shiga toxin-producing Escherichia coli infection as a precipitating factor for atypical hemolytic-uremic syndrome. Mortari G; Bigatti C; Gaffi GP; Lionetti B; Angeletti A; Matarese S; Verrina EE; Caridi G; Lugani F; Vellone VG; Chiarenza DS; La Porta E Pediatr Nephrol; 2024 Sep; ():. PubMed ID: 39347991 [TBL] [Abstract][Full Text] [Related]
6. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases. Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409 [TBL] [Abstract][Full Text] [Related]
7. [Atypical HUS caused by complement-related abnormalities]. Yoshida Y; Matsumoto M Rinsho Ketsueki; 2015 Feb; 56(2):185-93. PubMed ID: 25765799 [TBL] [Abstract][Full Text] [Related]
9. The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome. Avdonin PP; Blinova MS; Generalova GA; Emirova KM; Avdonin PV Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254639 [TBL] [Abstract][Full Text] [Related]
11. Hemolytic uremic syndrome in children. Talarico V; Aloe M; Monzani A; Miniero R; Bona G Minerva Pediatr; 2016 Dec; 68(6):441-455. PubMed ID: 27768015 [TBL] [Abstract][Full Text] [Related]
12. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring. Mannucci PM; Cugno M Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489 [TBL] [Abstract][Full Text] [Related]
13. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis. Laurence J; Haller H; Mannucci PM; Nangaku M; Praga M; Rodriguez de Cordoba S Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620 [TBL] [Abstract][Full Text] [Related]
15. [Atypical hemolytic uremic syndrome]. Blasco Pelicano M; Rodríguez de Córdoba S; Campistol Plana JM Med Clin (Barc); 2015 Nov; 145(10):438-45. PubMed ID: 25433773 [TBL] [Abstract][Full Text] [Related]
16. Where are we with haemolytic uremic syndrome? Cavero T; Alonso M Med Clin (Barc); 2018 Oct; 151(8):329-335. PubMed ID: 29699703 [TBL] [Abstract][Full Text] [Related]
18. [Pathophysiology of atypical hemolytic uremic syndrome. Ten years of progress, from laboratory to patient]. Frémeaux-Bacchi V Biol Aujourdhui; 2013; 207(4):231-40. PubMed ID: 24594571 [TBL] [Abstract][Full Text] [Related]
19. Atypical Hemolytic Uremic Syndrome (p.Gly1110Ala) with Autoimmune Disease. Park S; Lee YJ; Kim YW; Ko J; Park JH; Kim IH; Kim HJ; Oh D; Park BS Am J Case Rep; 2020 May; 21():e922567. PubMed ID: 32361709 [TBL] [Abstract][Full Text] [Related]